Ovagen
Mayo
About Ovagen
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $18.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: ovagen.ie
- Phone: +353 (0)96 75579
Industries & Categories
Biotechnology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/ovagen-76183 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.